| Tertiary lymphoid structures improve immunotherapy and survival in melanoma R Cabrita, M Lauss, A Sanna, M Donia, M Skaarup Larsen, S Mitra, ... Nature 577 (7791), 561-565, 2020 | 1473 | 2020 |
| Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma M Lauss, M Donia, K Harbst, R Andersen, S Mitra, F Rosengren, M Salim, ... Nature communications 8 (1), 1738, 2017 | 374 | 2017 |
| Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers D Glodzik, A Bosch, J Hartman, M Aine, J Vallon-Christersson, ... Nature communications 11 (1), 3747, 2020 | 63 | 2020 |
| The role of PTEN loss in immune escape, melanoma prognosis and therapy response R Cabrita, S Mitra, A Sanna, H Ekedahl, K Lövgren, H Olsson, C Ingvar, ... Cancers 12 (3), 742, 2020 | 49 | 2020 |
| Molecular analyses of triple-negative breast cancer in the young and elderly M Aine, C Boyaci, J Hartman, J Häkkinen, S Mitra, AB Campos, E Nimeus, ... Breast Cancer Research 23, 1-19, 2021 | 34 | 2021 |
| Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma S Mitra, M Lauss, R Cabrita, J Choi, T Zhang, K Isaksson, H Olsson, ... Molecular Oncology 14 (5), 933-950, 2020 | 33 | 2020 |
| Tumor genetic heterogeneity analysis of chronic sun‐damaged melanoma A Sanna, K Harbst, I Johansson, G Christensen, M Lauss, S Mitra, ... Pigment cell & melanoma research 33 (3), 480-489, 2020 | 29 | 2020 |
| Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data LH Betancourt, K Pawłowski, J Eriksson, AM Szasz, S Mitra, I Pla, ... Scientific reports 9 (1), 5154, 2019 | 13 | 2019 |
| DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype A Sanna, B Phung, S Mitra, M Lauss, J Choi, T Zhang, CN Njauw, ... JCI insight 7 (19), 2022 | 8 | 2022 |
| Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma: A potential treatment target in rare cases? S Mitra, S Sydow, L Magnusson, P Piccinelli, L Törnudd, I Øra, ... Genes, Chromosomes and Cancer 61 (1), 5-9, 2022 | 2 | 2022 |
| Insertion of the CXXC domain of KMT2A into YAP1: An unusual mechanism behind the formation of a chimeric oncogenic protein G Teku, J Nilsson, L Magnusson, S Sydow, U Flucke, F Puls, S Mitra, ... Genes, Chromosomes and Cancer 62 (11), 633-640, 2023 | 1 | 2023 |
| Exploring the Molecular Landscape of Cutaneous Melanoma S Mitra | 1 | 2020 |
Martin LaussDepartment of Oncology, Clinical Sciences, Lund University, SwedenVerified email at med.lu.se
